At baseline, patients in group B had a higher frequency of osteoporosis/osteopenia (p = 0.001) and visceral obesity (p = 0.020), higher WC values (p = 0.048) and lower osteocalcin levels (p = 0.004) than group A (Table 2). The gene discussed is BGLAP; the disease is osteoporosis.